サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1528121

人工臓器の世界市場

Artificial Organs

出版日
ページ情報
英文 288 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
人工臓器の世界市場
出版日: 2024年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 288 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

人工臓器の世界市場は2030年までに米国で432億米ドルに達する見込み

2023年に260億米ドルと推定される人工臓器の世界市場は、分析期間2023-2030年にCAGR 7.5%で成長し、2030年には432億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである人工腎臓は、CAGR 8.1%を記録し、分析期間終了時には231億米ドルに達すると予測されます。人工膵臓セグメントの成長率は、分析期間中CAGR 7.1%と推定されます。

米国市場は69億米ドルと推定、中国はCAGR 7.0％で成長すると予測

米国の人工臓器市場は2023年に69億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに67億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.8%と6.2%と予測されています。欧州では、ドイツがCAGR 5.7%で成長すると予測されています。

世界の人工臓器市場- 主要動向と促進要因まとめ

バイオニックマン：まだ想像の産物だが、徐々に、そして確実に近づいている

バイオニックマンが、SF映画の明滅するフレームの中だけでなく、私たちの日常の現実の一部として、私たちの間を歩いている世界を想像してみてください。人工心臓が鼓動を打ち、人工肺が呼吸をするたびに、この現代科学の驚異は人間の生物学の複雑なシンフォニーを映し出します。かつては研究室のホワイトボードに描かれたスケッチに過ぎなかった"人工臓器"は、今や彼の中で生命を脈打っています。彼の静脈は研究室で作られた血液で流れ、彼の目は高解像度カメラならではの鮮明さで見え、彼の指先は人間の皮膚の柔らかさを模倣するように設計され、優しく触れることができます。人工臓器のサイエンスは、奇跡的なイノベーションを起こしながら、この夢を現実の布に編み上げているのです。

人工臓器とは何か？

人工臓器は、機能不全に陥った自然臓器の代わりに、特定の機能または関連する機能群を回復させ、患者が通常の生活に戻れるよう、人体に移植または統合される生体工学的デバイスです。これには、人工心臓、人工腎臓、人工肝臓、最近ではバイオ人工膵臓、人工血管などが含まれます。人工臓器の開発は、生体医工学、材料科学、細胞生物学の進歩を組み合わせた複雑で学際的な分野です。このようなデバイスの統合は、臓器不全に苦しむ人々の生活の質を大幅に改善し、寿命を延ばすことができます。臓器提供者の世界の不足と、糖尿病や心臓病などの慢性疾患に関連した臓器不全の発生率の増加を考えると、これは特に重要です。

テクノロジーはどのように人工臓器の機能を進化させているのか？

技術の進歩は、人工臓器開発の進化の中核をなしています。最新の人工臓器は、生体適合性に優れ、複雑な生物学的機能を果たすことのできる高度な生体材料をますます取り入れています。例えば、心臓弁や血管に最先端のポリマーや複合材料を使用することで、人体組織の自然な弾力性や強度を模倣することができ、血栓のリスクを低減し、寿命を向上させることができます。さらに、3Dバイオプリンティングの開発は、臓器置換の可能性の限界を押し広げつつあり、複雑な組織や臓器構造のプリンティングを可能にしています。これらの技術は、人工臓器の性能を向上させるだけでなく、移植に伴う拒絶反応やその他の合併症のリスクを軽減します。

人工臓器が医療現場で直面する課題とは？

大きな進歩にもかかわらず、人工臓器の医療への統合はいくつかの課題に直面しています。その最たるものは、身体が異物を拒絶する傾向にあることで、深刻な合併症や装置の故障につながる可能性があります。このため、免疫系を抑制するための継続的な投薬治療が必要となり、長期的な健康リスクが生じる。さらに、人工臓器の耐久性と機能性は、天然のものと完全に一致しない場合があり、患者のQOLに影響を与える可能性があります。また、開発や導入にかかるコストが高いため、これらの技術を必要とする多くの人々には手が届かないです。さらに、新しい機器が安全かつ効果的であることを保証するためには、倫理的・規制的なハードルを乗り越えなければならないです。これらの課題に対処するには、継続的な調査と技術革新、そして技術の進歩に対応できる包括的な規制の枠組みが必要です。

人工臓器市場の成長の促進要因は？

人工臓器市場の成長は、これらのデバイスの有効性と安全性を高める技術革新など、いくつかの要因によってもたらされます。糖尿病や心臓病など、臓器不全につながる慢性疾患の有病率が上昇していることが、世界中で人工臓器の需要を高めています。先進諸国では人口の高齢化が進んでおり、高齢者ほど臓器置換を必要とする疾患に罹患する可能性が高いためです。さらに、ヘルスケア・インフラの改善と世界の医療支出の増加により、こうした高度な治療がより多くの人々にとって利用しやすくなっています。新興市場の経済発展により人工臓器市場の範囲がさらに拡大し、新たな採用の機会を提供しています。最後に、臓器提供の可能性という現在進行中の課題が、代替ソリューションの必要性を後押しし続け、世界中の患者の切実なニーズに応えようとする人工臓器業界の成長を後押ししています。

調査対象企業の例（注目の71社）

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP-1126

Global Artificial Organs Market to Reach US$43.2 Billion by 2030

The global market for Artificial Organs estimated at US$26.0 Billion in the year 2023, is expected to reach US$43.2 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Artificial Kidneys, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$23.1 Billion by the end of the analysis period. Growth in the Artificial Pancreas segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.9 Billion While China is Forecast to Grow at 7.0% CAGR

The Artificial Organs market in the U.S. is estimated at US$6.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.

Global Artificial Organs Market - Key Trends and Drivers Summarized

The Bionic Man: Still a Figment of Our Imagination, but We Are Getting There Slowly and Decisively

Imagine a world where the bionic man walks among us, not just in the flickering frames of a sci-fi film but as a part of our everyday reality. With each beat of his engineered heart and each breath drawn by synthetic lungs, this marvel of modern science mirrors the intricate symphony of human biology. Artificial organs, once mere sketches on research lab whiteboards, now pulse with life within him. His veins course with lab-crafted blood, his eyes see with the clarity only high-definition cameras can provide, and his touch is gentle with fingers engineered to mimic the softness of human skin. While the true incarnation of the bionic man remains nestled in the realm of future possibilities, the science of artificial organs is knitting this dream into the fabric of the probable, one miraculous innovation at a time.

What Are Artificial Organs, and How Are They Changing Lives?

Artificial organs are bioengineered devices that are implanted or integrated into human bodies to replace natural organs that have failed, restoring a specific function or a group of related functions to help the patient return to a normal life. These include artificial hearts, kidneys, livers, and more recently, bioartificial pancreases and synthetic blood vessels. The development of artificial organs is a complex, interdisciplinary field that combines advancements in biomedical engineering, materials science, and cellular biology. The integration of such devices can significantly improve the quality of life and extend the lifespan of individuals suffering from organ failure. This is especially critical given the global shortage of organ donors and the increasing incidence of organ failure linked to chronic diseases such as diabetes and heart disease.

How Is Technology Advancing the Functionality of Artificial Organs?

Technological advancements are at the core of the evolution in artificial organ development. Modern artificial organs are increasingly incorporating advanced biomaterials that are biocompatible and can perform complex biological functions. For instance, the use of cutting-edge polymers and composite materials in heart valves and blood vessels can mimic the natural elasticity and strength of human tissue, reducing the risk of blood clots and improving longevity. In addition, developments in 3D bioprinting are pushing the boundaries of what's possible in organ replacement, allowing for the printing of complex tissues and organ structures that could one day lead to fully functional, biologically active organs. These technologies not only enhance the performance of artificial organs but also reduce the risk of rejection and other complications associated with transplants.

What Challenges Do Artificial Organs Face in Medical Practice?

Despite significant advancements, the integration of artificial organs into medical practice faces several challenges. The foremost is the body's tendency to reject foreign objects, which can lead to serious complications or device failure. This necessitates ongoing medication regimes to suppress the immune system, posing long-term health risks. Additionally, the durability and functionality of artificial organs may not fully match those of their natural counterparts, which can affect the patient's quality of life. There is also the high cost of development and implementation, making these technologies inaccessible to many who need them. Furthermore, ethical and regulatory hurdles must be navigated to ensure that new devices are both safe and effective. Addressing these challenges requires continuous research and innovation, as well as comprehensive regulatory frameworks that can keep pace with technological advancement.

What Drives the Growth in the Artificial Organs Market?

The growth in the artificial organs market is driven by several factors, including technological innovations that enhance the effectiveness and safety of these devices. The rising prevalence of chronic diseases that lead to organ failure, such as diabetes and heart disease, is increasing the demand for artificial organs worldwide. Aging populations in developed countries also contribute to this demand, as older age groups are more likely to suffer from conditions requiring organ replacement. Additionally, improvements in healthcare infrastructure and increased healthcare spending globally make these advanced treatments more accessible to a broader audience. Economic development in emerging markets further expands the reach of the artificial organs market, providing new opportunities for adoption. Lastly, the ongoing challenges in donor organ availability continue to push the need for alternative solutions, bolstering the growth of the artificial organs industry as it works to meet the critical needs of patients worldwide.

Select Competitors (Total 71 Featured) -

  • Abbott Laboratories
  • Abiomed Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Baxter International Inc.
  • F.Hoffmann-La Roche Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • HeartWare International Inc.
  • Jarvik Heart Inc.
  • Medtronic Inc.
  • Nikkiso Co. Ltd.
  • Nipro Corp.
  • SynCardia Systems LLC
  • Toray Medical Co., Ltd.
  • Xenios AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Artificial Organs - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Breakthroughs in Biomaterials and Biocompatibility Expand Market Opportunities
    • Rising Incidence of Organ Failure and Limitations in Donor Availability Propel Demand
    • Advances in 3D Printing and Bioprinting Technologies Strengthen Market Potential
    • Growth in Healthcare Expenditure and Investments in Advanced Medical Technologies
    • Innovations in Artificial Heart and Kidney Devices Set the Stage for Growth
    • Ethical and Moral Challenges Impacting the Adoption of Artificial Organs
    • Technological Convergence in Robotics, Nanotechnology, and Biomedicine
    • Advances in Sensory and Feedback Technologies for Prosthetics and Implants
    • Innovations in Immunosuppression and Post-transplant Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Organs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Artificial Kidneys by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Artificial Kidneys by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Artificial Pancreas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Artificial Pancreas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Artificial Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Artificial Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Artificial Lungs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Artificial Lungs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • JAPAN
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Japan 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • CHINA
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: China 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • EUROPE
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Artificial Organs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • FRANCE
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: France 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • GERMANY
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Germany 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Italy 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: UK 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Artificial Organs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 56: Rest of World Recent Past, Current & Future Analysis for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Rest of World Historic Review for Artificial Organs by Segment - Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Rest of World 16-Year Perspective for Artificial Organs by Segment - Percentage Breakdown of Value Sales for Artificial Kidneys, Artificial Pancreas, Artificial Liver, Artificial Heart and Artificial Lungs for the Years 2014, 2024 & 2030

IV. COMPETITION